3-4 March 2026, RAI Congress Centre, Amsterdam

WORLD LEADING HEALTHCARE EVIDENCE, PRICING
AND ACCESS CONGRESS

image

d-fine


We're sponsoring the World EPA Congress 2026.

Come meet us!

REGISTER NOW   

What is World Evidence, Pricing and Access Congress Europe?

 

The World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 250 speakers, 10 tracks and 1500+ attendees from pharma, biotech and Payers/HTA’s.

 
Conference

Covering market access, pricing, reimbursement, rare diseases, health technology assessments, health economics and outcomes research in healthcare
 

Exhibition

120+ leading solution producers to meet your needs across evidence generation, market access, pricing, rare diseases and more to enable operational excellence
 

Networking

Networking is at the heart of the World Evidence Pricing and Access Congress. Our congress allows you to connect directly with key decision makers across 2 days of built in one to one networking



Confirmed Speakers

Patrick Hopkinson
Independent HTA Expert
Independent HTA Expert

Gina Ewy
Vice President, Head of Global Market Access
Hansa Biopharma

Christoph Glaetzer
Chief Global Value and Access Officer
Johnson & Johnson Innovative Medicine

Iroda Jurabekova
Global Director, Oncology Pricing and Market Access
Boehringer Ingelheim

Dilip Patel
SVP, Access & Market Development
Autolus

Sally Chung
Vice President, Value & Access International Operations & Excellence
Ipsen

Thomas Grub
Director, Global Pricing and Market Access
medac GmbH

Sandra Rose
Head of Market Access & Public Affairs
Chiesi

Hans Severens
Independent HTA Expert
Severens HTA consultancy

Henriette Burghoorn
Associate Director, Market Access
Gilead Sciences

Join Us In Amsterdam | 3-4 March 2026


REGISTER NOW